ArticlePharmaceuticals (Basel, Switzerland)2022

A Selective Inhibitor of Cardiac Troponin I Phosphorylation by Delta Protein Kinase C (δPKC) as a Treatment for Ischemia-Reperfusion Injury.

Nir Qvit et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.